“ϊ–{ˆγ‰Θ‘εŠwˆγŠw‰οŽGŽ Online Journal ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚π”ς‚Ξ‚·
‘–ΪŽŸ > †–ΪŽŸ > Abstract ƒz[ƒ€‚Φ–ί‚ι
Abstract

‘ζ14Šͺ 2018”N10ŒŽ@‘ζ4†

‘S•ΆPDF (180K)

‘“ΑWkŠeŽνŠΰ‚Μ•ͺŽq•W“I—Γ–@‚ΜŒ»‹΅‚Ζ“WŠJl‘ζ28‰ρŒφŠJuƒVƒ“ƒ|ƒWƒEƒ€v

”xŠΰ‚Μ•ͺŽq•W“I—Γ–@
΄‰Ζ@³”Ž
“ϊ–{ˆγ‰Θ‘εŠw‘εŠw‰@ˆγŠwŒ€‹†‰ΘŒΔ‹zŠν“ΰ‰ΘŠw•ͺ–μ

Molecular Targeted Therapy of Lung Cancer
Masahiro Seike
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School

“ϊˆγ‘εˆγ‰οŽ 2018; 14(4), 177-179

Key words
lung cancer, molecular targeted therapy, immuno-oncology

Correspondence to
Masahiro Seike, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
E-mailFmseike@nms.ac.jp

Žσ•tF2018”N9ŒŽ25“ϊ@Žσ—F2018”N9ŒŽ27“ϊ

ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚Φ–ί‚ι ‚±‚Μƒy[ƒW‚Μƒgƒbƒv‚Φ–ί‚ι